A Phase 1 Open Label Multi-Arm Multicenter Study of MK-4830 as Monotherapy and in Combination with Pembrolizumab for Participants with Advanced Solid Tumors
If you are registered as a volunteer, please log in to contact the study team/express interest in this study.
